0GV5 Stock Chart & Stats
€4.21
-€0.10(-2.13%)
At close: 4:00 PM EST
€4.21
-€0.10(-2.13%)
Day’s Range― - ―
52-Week Range€3.37 - €5.25
Previous CloseN/A
Volume807.75K
Average Volume (3M)258.00
Market Cap
€898.59M
Enterprise Value€1.03K
Total Cash (Recent Filing)€96.46M
Total Debt (Recent Filing)€328.51M
Price to Earnings (P/E)21.1
Beta0.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding189,177,690
10 Day Avg. Volume81
30 Day Avg. Volume258
Financial Highlights & Ratios
PEG Ratio-0.82
Price to Book (P/B)1.64
Price to Sales (P/S)1.69
P/FCF Ratio75.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€6.40Price Target Upside52.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe strong TTM revenue rebound indicates renewed demand across GVS’s filtration markets. Sustained growth would improve operating leverage and support investment in healthcare, life-science, and industrial applications, although continued execution is needed.
Cash GenerationStrong recent free cash flow gives GVS internal funding for capacity, product development, and debt service. Cash generation covering a substantial share of earnings supports financial resilience and reduces reliance on external capital.
Recurring Design-In DemandRecurring consumables and design-in components can create durable customer relationships and switching barriers. Validation and qualification requirements in healthcare and life sciences may further support repeat orders and revenue visibility.
Bears Say
Gross Margin PressureThe sharp decline in gross margin suggests cost pressure or unfavorable mix, which could limit the benefit of revenue growth. Persistent margin weakness would reduce earnings quality and constrain reinvestment across GVS’s businesses.
Historical Leverage RiskCurrent leverage appears manageable, but the prior increase shows that GVS’s balance sheet can become more exposed during weaker periods or expansion. A renewed rise in debt could restrict flexibility if profitability softens.
Cash Conversion VolatilityAlthough recent cash generation is strong, inconsistent year-to-year conversion indicates exposure to working-capital movements or investment requirements. This volatility can make funding capacity less predictable and complicate long-term capital allocation.
GVS S.p.A News
0GV5 FAQ
What was GVS S.p.A’s price range in the past 12 months?
GVS S.p.A lowest share price was €3.37 and its highest was €5.25 in the past 12 months.
What is GVS S.p.A’s market cap?
GVS S.p.A’s market cap is €898.59M.
When is GVS S.p.A’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GVS S.p.A’s earnings last quarter?
Currently, no data Available
Is GVS S.p.A overvalued?
According to Wall Street analysts GVS S.p.A’s price is currently Undervalued.
Does GVS S.p.A pay dividends?
GVS S.p.A does not currently pay dividends.
What is GVS S.p.A’s EPS estimate?
GVS S.p.A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GVS S.p.A have?
GVS S.p.A has 189,177,690 shares outstanding.
What happened to GVS S.p.A’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GVS S.p.A?
Currently, no hedge funds are holding shares in GB:0GV5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GVS S.p.A
GVS S.p.A., together with its subsidiaries, produces and sells filter solutions for applications in the healthcare and life sciences, energy and mobility, and health and safety sectors in Italy and internationally. The company offers health and safety products, such as hand dryer and vacuum cleaner filters; nailstation COSMO products; fume extraction and HVAC building products; and disposable masks, half masks, integra masks, powered air purifying respirators, face fit testing, replacement filters, supplied air respirators, spare parts, and accessories. It also provides autoclave filters, insufflation and ventilation filters and kits, machine filters, respiratory and anesthesia filters, smoke evacuation filters and kits, spirometry filters and accessories, suction filters, and tracheal humidifier filters; healthcare liquid products, such as bacterial air vents, blood tubular filters, infusion disc filters, IV and liquid filters, IV flow regulators, medical bags and components, sterile infusion sets and accessories, stopcock and manifold products, and transducer protectors; and capsule and cartridge filters, disc and sheet membranes, mini roll membranes, DNA/RNA test kits, filter papers, microbiology products, microfiltration devices, microporous and track etched roll membranes, protein microarrays, and environmental monitoring products, as well as western blotting membranes and reagents. In addition, the company offers energy and mobility products, such as fuel tanks and pumps, metal components, reservoirs, and SCR urea systems; ABS, ESP, and brake systems; EV applications and batteries; injection, tank vapour ventilation, and transmission products; ventilation systems; and cabin air and HVAC systems, and engine air intake ventilation filters. The company was formerly known as GVS S.r.l. and changed its name to GVS S.p.A. in 2001. GVS S.p.A. was founded in 1979 and is headquartered in Zola Predosa, Italy. GVS S.p.A. is a subsidiary of GVS Group S.r.l.
0GV5 Stock 12 Month Forecast
Average Price Target
€6.40
▲(52.02% Upside)
Technical Analysis
Comer Industries SpA
―
ILPRA SpA
―
Industrie De Nora SpA
―
LU-VE SpA
―
Marzocchi Pompe S.p.A.
―




